Literature DB >> 1328408

Colposcopic and histologic findings and human papillomavirus (HPV) DNA test variability in young women positive for HPV DNA.

A B Moscicki1, J M Palefsky, J Gonzales, G Smith, G K Schoolnik.   

Abstract

The purpose of this study was to determine the prevalence of human papillomavirus (HPV)-related disease in women positive for HPV DNA by using a commercially available DNA detection kit and to compare these results to HPV DNA variability observed in repeated sampling. Young women attending family planning clinics who were positive for HPV DNA on routine screening were asked to return for a repeat HPV DNA test, cytology, colposcopy, and biopsy if indicated. Of the 78 women examined, 35% had biopsy-verified low-grade dysplasia of the cervix, and 64% had evidence of HPV-related disease somewhere in the anogenital area. Fifty percent of the women had a negative test on repeat sampling, but there was no association between DNA persistence at the second visit and colposcopic/histologic findings. In conclusion, the minority of women positive for HPV DNA have latent infection. In addition, variability in detection is common and unrelated to the presence of HPV-related disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328408     DOI: 10.1093/infdis/166.5.951

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Oestrogen receptor transcripts associated with cervical human papillomavirus infection.

Authors:  M L Shew; R McGlennen; N Zaidi; M Westerheim; M Ireland; S Anderson
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

2.  The detection of HPV DNA, the size of tampon specimens and the menstrual cycle.

Authors:  C K Fairley; P M Robinson; S Chen; S N Tabrizi; S M Garland
Journal:  Genitourin Med       Date:  1994-06

Review 3.  Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis.

Authors:  Jill Koshiol; Lisa Lindsay; Jeanne M Pimenta; Charles Poole; David Jenkins; Jennifer S Smith
Journal:  Am J Epidemiol       Date:  2008-05-15       Impact factor: 4.897

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.